$ISOLF News
ISODIOL INTERNATIONAL INC. SIGNS DEFINITIVE AGREEMENT TO ACQUIRE BRADLEY'S BIOSCIENCE INC., AND CLOSES STRATEGIC FINANCING
Isodiol International Inc. has entered into a definitive agreement in connection with its previously announced letter of intent to acquire Bradley's Bioscience Inc., a leading manufacturer and distributer of hemp oil and nicotine e-liquids.
"The acquisition of Bradley's Bioscience, a market poised to be a $61.4-billion industry by 2025 is another major milestone for the company," said Marcos Agramont, chief executive officer of Isodiol. "Not only does this allow the company to penetrate a new market, but we are now also able to provide consumers with a safer alternative to smoking. Over all, we believe Bradley's Bioscience is a perfect fit with Isodiol and our long-term vision and we are very pleased to be moving forward with this agreement."